Cullinan Therapeutics
CGEM
#6099
Rank
A$1.54 B
Marketcap
A$25.15
Share price
-2.27%
Change (1 day)
104.82%
Change (1 year)

Cullinan Therapeutics (CGEM) - Total debt

Total debt on the balance sheet as of March 2026 : A$3.39 Million

According to Cullinan Therapeutics's latest financial reports the company's total debt is A$3.39 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cullinan Therapeutics - Total debt on balance sheet (from 2021 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$4 M15.83%
2024-12-31A$3.45 M-34.37%
2023-12-31A$5.26 M-30.9%
2022-12-31A$7.62 M
2021-12-31N/A